1-3 of 3
Keywords: Autologous hematopoietic stem cell transplantation
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

To Wash or Not to Wash? Comparison of Patient Outcome after Infusion of Cryopreserved Autologous Hematopoietic Stem Cells before and after the Replacement of Manual Washing by Bedside Thawing

Subject Area:
Hematology , Oncology
Anna Margret Halldorsdottir, Sveinlaug Atladottir, Margret A. Thorsteinsdottir, Niels A. Arnason, Gudmundur Runarsson, Torbjorn Jonsson, Olafur E. Sigurjonsson, Sigrun Reykdal
Journal: Acta Haematologica
Acta Haematol (2018) 140 (3): 169–175.
https://doi.org/10.1159/000492741
Published Online: 09 October 2018
... transfusion infusion set. All patients in both groups received premedication with Solu-Cortef, clemastine, and ondansetron prior to infusion of the graft. Information on all transplantations performed at the Landspitali, since the introduction of the autologous hematopoietic stem cell transplantation...
View article titled, To Wash or Not to Wash? Comparison of Patient Outcome after Infusion of Cryopreserved Autologous Hematopoietic Stem Cells before and after the Replacement of Manual Washing by Bedside Thawing
Open the PDF for To Wash or Not to Wash? Comparison of Patient Outcome after Infusion of Cryopreserved Autologous Hematopoietic Stem Cells before and after the Replacement of Manual Washing by Bedside Thawing in another window
Journal Articles

Delayed Development of Hemolytic Anemia with Fragmented Red Blood Cells and Cardiac and Renal Impairments after High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma

Subject Area:
Hematology , Oncology
Futoshi Iioka, Yusuke Toda, Yuya Nagai, Takashi Akasaka, Daiki Shimomura, Katsuyo Tsuda, Fumihiko Nakamura, Hitoshi Ohno
Journal: Acta Haematologica
Acta Haematol (2017) 138 (3): 152–161.
https://doi.org/10.1159/000480288
Published Online: 04 October 2017
...Futoshi Iioka; Yusuke Toda; Yuya Nagai; Takashi Akasaka; Daiki Shimomura; Katsuyo Tsuda; Fumihiko Nakamura; Hitoshi Ohno Among 42 consecutive patients with malignant lymphoma who underwent high-dose chemotherapy (HDC) followed by autologous hematopoietic stem cell transplantation (AHSCT), 5...
View article titled, Delayed Development of Hemolytic Anemia with Fragmented Red Blood Cells and Cardiac and Renal Impairments after High-Dose Chemotherapy and <span class="search-highlight">Autologous</span> <span class="search-highlight">Hematopoietic</span> <span class="search-highlight">Stem</span> <span class="search-highlight">Cell</span> <span class="search-highlight">Transplantation</span> for Malignant Lymphoma
Open the PDF for Delayed Development of Hemolytic Anemia with Fragmented Red Blood Cells and Cardiac and Renal Impairments after High-Dose Chemotherapy and <span class="search-highlight">Autologous</span> <span class="search-highlight">Hematopoietic</span> <span class="search-highlight">Stem</span> <span class="search-highlight">Cell</span> <span class="search-highlight">Transplantation</span> for Malignant Lymphoma in another window
Journal Articles

Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin

Subject Area:
Hematology , Oncology
Leona A. Holmberg, Pamela S. Becker, William Bensinger
Journal: Acta Haematologica
Acta Haematol (2017) 137 (3): 123–131.
https://doi.org/10.1159/000455937
Published Online: 30 March 2017
...Leona A. Holmberg; Pamela S. Becker; William Bensinger Background: In multiple myeloma (MM), relapse is a problem after autologous hematopoietic stem cell transplantation (ASCT). In the nontransplant setting, thalidomide/dexamethasone/clarithromycin (BLT-D) and lenalidomide/dexamethasone...
View article titled, Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin
Open the PDF for Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin in another window